IL-33 exacerbates periodontal disease through induction of RANKL

Journal of Dental Research

Volumn 94, Issue 7, 2015, Pages 968-975

  Malcolm, J ^a   Awang, R A ^b   Oliver Bell, J ^a   Butcher, J P ^a,d   Campbell, L ^a,b   Adrados Planell, A ^a,b   Lappin, D F ^b   Fukada, S Y ^a,e   Nile, C J ^b   Liew, F Y ^a,c   Culshaw, S ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^d UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cytokines; gingiva; OPG; periodontitis; Porphyromonas gingivalis; ST2

Indexed keywords

BACTERIUM ANTIBODY; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN; IL1RL1 PROTEIN, MOUSE; IL33 PROTEIN, HUMAN; IMMUNOGLOBULIN G; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; INTERLEUKIN-33, MOUSE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TNFRSF11B PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE;

ALVEOLAR BONE LOSS; ANIMAL; ANTAGONISTS AND INHIBITORS; B LYMPHOCYTE; BACTEROIDACEAE INFECTION; BAGG ALBINO MOUSE; BLOOD; CHRONIC PERIODONTITIS; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; GINGIVA; HUMAN; IMMUNOLOGY; JAW; LYMPH NODE; LYMPHOCYTE; MAXILLA; MICROBIOLOGY; MOUSE; PATHOLOGY; PORPHYROMONAS GINGIVALIS; T LYMPHOCYTE;

ALVEOLAR BONE LOSS; ALVEOLAR PROCESS; ANIMALS; ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; BACTEROIDACEAE INFECTIONS; CHRONIC PERIODONTITIS; DISEASE MODELS, ANIMAL; FEMALE; GINGIVA; HUMANS; IMMUNOGLOBULIN G; INTERLEUKINS; LYMPH NODES; LYMPHOCYTES; MAXILLA; MICE; MICE, INBRED BALB C; OSTEOPROTEGERIN; PORPHYROMONAS GINGIVALIS; RANK LIGAND; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN; T-LYMPHOCYTES;

EID: 84935113140     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034515577815     Document Type: Article

References (32)

1. Arenas-Hernandez M, Vega-Sanchez R. 2013. Housekeeping gene expression stability in reproductive tissues after mitogen stimulation. BMC Res Notes. 6:285.
2. Baker PJ, Evans RT, Roopenian DC. 1994. Oral infection with Porphyromonas gingivalis and induced alveolar bone loss in immunocompetent and severe combined immunodeficient mice. Arch Oral Biol. 39(12):1035-1040.
3. Bar M, Bar D, Lehmann B. 2009. Selection and validation of candidate housekeeping genes for studies of human keratinocytes-review and recommendations. J Invest Dermatol. 129(3):535-537.
4. Bologna-Molina R, Damián-Matsumura P, Molina-Frechero N. 2011. An easy cell counting method for immunohistochemistry that does not use an image analysis program. Histopathology. 59(4):801-803.
5. Buduneli N, Özçaka Ö, Nalbantsoy A. 2012. Interleukin-33 levels in gingival crevicular fluid, saliva, or plasma do not differentiate chronic periodontitis. J Periodontol. 83(3):362-368.
6. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP. 2007. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A. 104(1):282-287.
7. Gmur R, Hrodek K, Saxer UP, Guggenheim B. 1986. Double-blind analysis of the relation between adult periodontitis and systemic host response to suspected periodontal pathogens. Infect Immun. 52(3):768-776.
8. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA, Mcintosh ML, Alsam A, Kirkwood KL, Lambris JD, et al. 2011. Lowabundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 10(5):497-506.
9. Han X, Kawai T, Eastcott JW, Taubman MA. 2006. Bacterial-responsive B lymphocytes induce periodontal bone resorption. J Immunol. 176(1):625-631.
10. Han X, Lin X, Yu X, Lin J, Kawai T, Larosa KB, Taubman MA. 2013. Porphyromonas gingivalis infection-associated periodontal bone resorption is dependent on receptor activator of NF-kappaB ligand. Infect Immun. 81(5):1502-1509.
11. Hueber AJ, Alves-Filho JC, Asquith DL, Michels C, Millar NL, Reilly JH, Graham GJ, Liew FY, Miller AM, Mcinnes IB. 2011. IL-33 induces skin inflammation with mast cell and neutrophil activation. Eur J Immunol. 41(8):2229-2237.
12. Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, Goncalves RB, Valverde P, Dibart S, Li YP, et al. 2006. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol. 169(3):987-998.
13. Komai-Koma M, Gilchrist DS, Mckenzie AN, Goodyear CS, Xu D, Liew FY. 2011. IL-33 activates B1 cells and exacerbates contact sensitivity. J Immunol. 186(4):2584-2591.
14. Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, Mccabe S, et al. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 402(6759):304-309.
15. Kursunlu SF, Oztürk V?, Han B, Atmaca H, Emingil G. 2015. Gingival crevicular fluid interleukin-36beta (-1F8), interleukin-36gamma (-1F9) and interleukin-33 (-1F11) levels in different periodontal disease. Arch Oral Biol. 60(1):77-83.
16. Liang S, Krauss JL, Domon H, Mcintosh ML, Hosur KB, Qu H, Li F, Tzekou A, Lambris JD, Hajishengallis G. 2011. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J Immunol. 186(2):869-877.
17. Liew FY, Pitman NI, Mcinnes IB. 2010. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 10(2):103-110.
18. Lin X, Han X, Kawai T, Taubman MA. 2011. Antibody to receptor activator of NF-kappaB ligand ameliorates T cell-mediated periodontal bone resorption. Infect Immun. 79(2):911-917.
19. Luthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C, Brumatti G, Taylor RC, Kersse K, Vandenabeele P, et al. 2009. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity. 31(1):84-98.
20. Mooney J, Adonogianaki E, Kinane DF. 1993. Relative avidity of serum antibodies to putative periodontopathogens in periodontal disease. J Periodontal Res. 28(6 Pt 1):444-450.
21. Moussion C, Ortega N, Girard JP. 2008. The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One. 3(10):e3331.
22. Nile CJ, Barksby E, Jitprasertwong P, Preshaw PM, Taylor JJ. 2010. Expression and regulation of interleukin-33 in human monocytes. Immunology. 130(2):172-180.
23. Oliver-Bell J, Butcher JP, Malcolm J, Macleod MK, Adrados Planell A, Campbell L, Nibbs RJ, Garside P, Mcinnes IB, Culshaw S. 2015. Periodontitis in the absence of B cells and specific anti-bacterial antibody. Mol Oral Microbiol. 30(2):160-169.
24. Papathanasiou E, Teles F, Griffin T, Arguello E, Finkelman M, Hanley J, Theoharides TC. 2014. Gingival crevicular fluid levels of interferongamma, but not interleukin-4 or -33 or thymic stromal lymphopoietin, are increased in inflamed sites in patients with periodontal disease. J Periodontal Res. 49(1):55-61.
25. Schmittgen TD, Livak KJ. 2008. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3(6):1101-1108.
26. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, Mcclanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, et al. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 23(5):479-490.
27. Taubman MA, Kawai T. 2001. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit Rev Oral Biol Med. 12(2):125-135.
28. Teng YT, Nguyen H, Gao X, Kong YY, Gorczynski RM, Singh B, Ellen RP, Penninger JM. 2000. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest. 106(6):R59-R67.
29. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, Mckenzie AN. 2000. T1/ ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med. 191(6):1069-1076.
30. Xu D, Chan WL, Leung BP, Huang F, Wheeler R, Piedrafita D, Robinson JH, Liew FY. 1998. Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells. J Exp Med. 187(5):787-794.
31. Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR, Pitman N, Kurowska-Stolarska M, Mckenzie AN, Mcinnes IB, et al. 2008. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A. 105(31):10913-10918.
32. Xu D, Jiang HR, Li Y, Pushparaj PN, Kurowska-Stolarska M, Leung BP, Mu R, Tay HK, Mckenzie AN, Mcinnes IB, et al. 2010. IL-33 exacerbates autoantibody-induced arthritis. J Immunol. 184(5):2620-2626.